80 Categories, One Product: How to Get Cosmetic Product Categorisation Right in India
The Categorisation Problem Of all the challenges in India’s Cosmetic Import registration process, product categorisation is one of the most underestimated. Under the Cosmetics Rules, 2020, CDSCO has prescribed 80 Cosmetic categories under the Fourth Schedule. Every product included in a COS-1 application must be mapped to the appropriate category […]
Read MoreDecoding Government Fees for Cosmetic Import Registration in India
Introduction: The Cost Question Every Importer Asks First Before a global Cosmetic brand commits to entering the Indian market, one of the first questions its regulatory or finance team asks is: what will the government registration fees cost? The answer is more nuanced than it first appears — and underestimating […]
Read MoreThe New CDSCO Environment: What Global Pharmaceutical Companies Must Know in 2026
Introduction India’s Pharmaceutical regulatory landscape is undergoing its most significant transformation in decades. For global Pharmaceutical companies — whether entering the Indian market for the first time or managing long-standing manufacturing operations — understanding the new CDSCO environment is no longer optional. It is a strategic imperative. The Central Drugs […]
Read More
Authorized Agent for Medical Device Import in India: When You Need One and How to Choose the Right Partner
For foreign Medical Device companies entering India, the authorized agent is not just a compliance checkpoint — it is a strategic regulatory role. The right appointment can support licensing procedure, smoother filings, and long-term business flexibility. The wrong appointment can create dependency, rework, and disruption later. CliniExperts’ Importer page positions […]
Read More
The Complete Roadmap to Cosmetic Import Registration in India
India’s Cosmetic Market and Why Registration Matters India’s Cosmetic and personal care market has grown into one of the most consequential in the Asia-Pacific region — valued at over USD 6 billion and expanding at a compound annual growth rate that consistently outpaces global averages. For a global Cosmetic brand, […]
Read More
Medical Device Classification in India: Class A, B, C, and D Explained for Importers and Manufacturers
Medical Device classification is one of the first decisions that shapes a successful regulatory strategy in India. Whether a company plans to manufacture locally in India or import into the Indian market, the classification assigned to the device influences the MD forms, documentation, licensing route, audit and level of regulatory […]
Read MoreRegulation/Guidelines
How to Obtain CDSCO Approval for Biosimilars in India: Complete 2026 Regulatory Pathway
Why India Demands a Dedicated Biosimilar Strategy India is one of the fastest-growing Biosimilar markets in the world, driven by a large patient population, expanding government healthcare coverage under Ayushman Bharat, and increasing physician acceptance of Biosimilar therapies. For global manufacturers, India represents both a significant commercial opportunity and a […]
Regulation/Guidelines
Why Pharmaceutical Manufacturers Fail Regulatory Due Diligence Before Acquisition
Pharmaceutical acquisitions are complex, high-stakes transactions. Financial modelling, commercial valuation, and market positioning typically receive the most intensive scrutiny. Yet the most consequential risks in many transactions are neither financial nor commercial — they are regulatory. Regulatory due diligence failures in Pharmaceutical M&A are not rare. They surface repeatedly after […]
Regulation/Guidelines
SUGAM Portal Registration for Medical Devices: Common Errors That Delay Approval
The SUGAM portal plays an important l role in India’s Medical Device regulatory workflow. SUGAM portal has replaced the manual fillings of applications. Now it helps to connect the applicants, regulators and reviewers with a centralized framework. Through SUGAM portal one can submit applications, upload documents, respond to queries raised […]